Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Contineum Therapeutics, Inc. Class A (CTNM)
NASDAQ:CTNM
RESEARCH TOOLSreports
Holding CTNM?
Track your performance easily
Contineum Therapeutics, Inc. Class A (CTNM) Ownership Overview
2.83% Insiders
2.86% Mutual Funds
54.72% Other Institutional Investors
39.60% Public Companies and
Individual Investors
The ownership structure of Contineum Therapeutics, Inc. Class A (CTNM) stock is a mix of institutional, retail and individual investors. Approximately 57.57% of the company’s stock is owned by Institutional Investors, 2.83% is owned by Insiders and 39.60% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $1174005 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $5503125 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $15849000 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $16168850 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 918,163 | Institution | 4.83% | 18,418,350 | |
| 900,000 | Institution | 4.74% | 18,054,000 | |
| 453,942 | Institution | 2.39% | 9,106,077 | |
| 312,500 | Institution | 1.65% | 6,268,750 | |
| 264,800 | Institution | 1.39% | 5,311,888 | |
| 243,860 | Institution | 1.28% | 4,891,832 | |
| 216,967 | Institution | 1.14% | 4,352,358 | |
| 66,667 | Institution | 0.35% | 1,337,340 | |
| 58,800 | Institution | 0.31% | 1,179,528 | |
| 32,042 | Institution | 0.17% | 642,763 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 264,800 | Institution | 1.39% | 5,311,888 | |
| 216,967 | Institution | 1.14% | 4,352,358 | |
| 58,800 | Institution | 0.31% | 1,179,528 | |
| 1,796 | Institution | <0.01% | 36,028 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 299,583 | Institution | 1.58% | 6,009,635 | |
| 169,484 | Institution | 0.89% | 3,399,849 | |
| 120,636 | Institution | 0.64% | 2,419,958 | |
| 33,970 | Institution | 0.18% | 681,438 | |
| 32,042 | Institution | 0.17% | 584,446 | |
| 27,306 | Institution | 0.14% | 547,758 | |
| 23,937 | Institution | 0.13% | 480,176 | |
| 16,469 | Institution | 0.09% | 330,368 | |
| 4,886 | Institution | 0.03% | 98,013 | |
| 4,034 | Institution | 0.02% | 80,922 |
FAQ
Who Owns Contineum Therapeutics, Inc. Class A (CTNM)?
According to the latest TipRanks data, approximately 54.72% of the company's stock is held by institutional investors, 2.83% is held by insiders, and 39.60% is held by retail investors.
What percentage of Contineum Therapeutics, Inc. Class A (CTNM) stock is held by institutional investors?
According to the latest TipRanks data, approximately 54.72% of Contineum Therapeutics, Inc. Class A (CTNM) stock is held by institutional investors.
What percentage of Contineum Therapeutics, Inc. Class A (CTNM) stock is held by retail investors?
According to the latest TipRanks data, approximately 39.60% of Contineum Therapeutics, Inc. Class A (CTNM) stock is held by retail investors.
Who owns the most shares of Contineum Therapeutics, Inc. Class A (CTNM)?
Brad Bolzon owns the most shares of Contineum Therapeutics, Inc. Class A (CTNM).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.